BRPI0920216A2 - forma de dosagem intraoral em múltiplas porções e uso das mesmas - Google Patents

forma de dosagem intraoral em múltiplas porções e uso das mesmas

Info

Publication number
BRPI0920216A2
BRPI0920216A2 BRPI0920216A BRPI0920216A BRPI0920216A2 BR PI0920216 A2 BRPI0920216 A2 BR PI0920216A2 BR PI0920216 A BRPI0920216 A BR PI0920216A BR PI0920216 A BRPI0920216 A BR PI0920216A BR PI0920216 A2 BRPI0920216 A2 BR PI0920216A2
Authority
BR
Brazil
Prior art keywords
dose
dosage form
intraoral dosage
intraoral
dose intraoral
Prior art date
Application number
BRPI0920216A
Other languages
English (en)
Inventor
Hugerth Andreas
Bunick Frank
Nicklasson Fredrik
Luber Joe
Lindell Katarina
Thyresson Kristina
Original Assignee
Mcneil Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42106720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0920216(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mcneil Ab filed Critical Mcneil Ab
Publication of BRPI0920216A2 publication Critical patent/BRPI0920216A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0920216A 2008-10-14 2009-10-13 forma de dosagem intraoral em múltiplas porções e uso das mesmas BRPI0920216A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0802189 2008-10-14
PCT/SE2009/051163 WO2010044736A1 (en) 2008-10-14 2009-10-13 Multi portion intra-oral dosage form and use thereof

Publications (1)

Publication Number Publication Date
BRPI0920216A2 true BRPI0920216A2 (pt) 2019-09-24

Family

ID=42106720

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0920216A BRPI0920216A2 (pt) 2008-10-14 2009-10-13 forma de dosagem intraoral em múltiplas porções e uso das mesmas

Country Status (15)

Country Link
EP (1) EP2361081B1 (pt)
JP (1) JP2012505878A (pt)
KR (1) KR20110071008A (pt)
CN (1) CN102186461A (pt)
AR (1) AR073851A1 (pt)
AU (1) AU2009303979A1 (pt)
BR (1) BRPI0920216A2 (pt)
CA (1) CA2737307A1 (pt)
DK (1) DK2361081T3 (pt)
ES (1) ES2592882T3 (pt)
MX (1) MX2011003984A (pt)
NZ (1) NZ591710A (pt)
PT (1) PT2361081T (pt)
RU (1) RU2011119494A (pt)
WO (1) WO2010044736A1 (pt)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2446881T3 (pl) 2003-07-24 2014-08-29 Glaxosmithkline Llc Folie rozpuszczające się w jamie ustnej
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
CL2009001025A1 (es) 2008-05-01 2010-09-24 Smithkline Beecham Corp Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.
EP2233134A1 (en) * 2009-03-27 2010-09-29 McNeil AB Multi-portion intra-oral dosage form with organoleptic properties
WO2011041414A1 (en) 2009-09-30 2011-04-07 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
DE102010024866A1 (de) * 2010-06-24 2011-12-29 Pharmatech Gmbh Formulierung zur Geschmacksmaskierung
US9675102B2 (en) * 2010-09-07 2017-06-13 R. J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
KR101825972B1 (ko) 2010-10-15 2018-02-06 콘테라 파르마 에이피에스 운동 장애 치료를 위한 세로토닌 수용체 작용제의 조합
PL2491788T3 (pl) 2011-02-25 2016-07-29 Kraft Foods R & D Inc Wyrób spożywczy z formowanym korpusem
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US20130177646A1 (en) * 2012-01-05 2013-07-11 Mcneil Ab Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance
US12285025B2 (en) 2012-02-10 2025-04-29 R.J. Reynolds Tobacco Company Multi-layer smokeless tobacco composition
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) * 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
PT2838517T (pt) 2012-04-18 2018-01-04 Contera Pharma Aps Formulação farmacêutica disponível sob forma oral adequada para a melhoria da gestão dos distúrbios da mobilidade
PL220354B1 (pl) 2012-11-19 2015-10-30 Aflofarm Fabryka Leków Spółka Z Ograniczoną Odpowiedzialnością Stała postać dawkowania zawierająca zmikronizowaną cytyzynę oraz sposób jej otrzymywania
RU2503447C1 (ru) * 2012-11-20 2014-01-10 Максим Эдуардович Запольский Лекарственное средство в форме ородисперсной таблетки и способ получения лекарственного средства
WO2014085599A1 (en) 2012-11-30 2014-06-05 Acura Pharmaceuticals, Inc. Self-regulated release of active pharmaceutical ingredient
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US20150290107A1 (en) * 2013-03-14 2015-10-15 3 In 1 Dental Pllc Compositions for treatment of xerostomia and for tooth treatment
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
WO2014143019A1 (en) * 2013-03-15 2014-09-18 Colgate-Palmolive Company Oral care compositions
RU2016106907A (ru) * 2013-07-31 2017-09-01 Интелдженкс Корп. Мгновенно смачивающаяся пероральная пленочная лекарственная форма без поверхностно-активного вещества или полиспирта
AU2014306759B2 (en) 2013-08-12 2018-04-26 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US10105320B2 (en) 2013-10-03 2018-10-23 Altria Client Services Soluble fiber lozenge
US12274276B2 (en) 2013-10-03 2025-04-15 Altria Client Services Llc Dissolvable-chewable tablet
US11779045B2 (en) 2013-10-03 2023-10-10 Altria Client Services Llc Dissolvable-chewable exhausted-tobacco tablet
US9999243B2 (en) 2013-10-03 2018-06-19 Altria Client Services Llc Exhausted tobacco lozenge
US9351936B2 (en) 2013-10-03 2016-05-31 Altria Client Services Llc Nicotine lozenge
US10244786B2 (en) 2013-10-03 2019-04-02 Altria Client Services Llc Tobacco lozenge
EP3881824B1 (en) 2013-10-03 2024-12-04 Altria Client Services LLC Lozenge
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10508096B2 (en) 2014-05-27 2019-12-17 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
WO2015183801A1 (en) 2014-05-27 2015-12-03 R. J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
US9896429B2 (en) 2014-05-27 2018-02-20 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
GB201411526D0 (en) 2014-06-27 2014-08-13 British American Tobacco Co Powder
EP3169315B1 (en) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
KR101506708B1 (ko) 2014-09-03 2015-03-30 주식회사 다림바이오텍 금연 보조용 설하분무제와 트로키를 제조하는 방법 및 이에 의하여 제조된 설하분무제와 트로키
US20160106737A1 (en) 2014-10-20 2016-04-21 Pharmaceutical Manufacturing Research Services, Inc. Extended Release Abuse Deterrent Liquid Fill Dosage Form
US20160198759A1 (en) * 2015-01-13 2016-07-14 Zip Llc E-cigarette or vaping fluid
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
CN105343887B (zh) * 2015-10-30 2018-04-27 济南康和医药科技有限公司 一种右佐匹克隆口腔速溶膜及其制备方法
CN105581991A (zh) * 2015-12-28 2016-05-18 安徽省逸欣铭医药科技有限公司 一种酒石酸唑吡坦舌下片及其制备方法
CA3030089C (en) 2016-07-11 2024-04-23 Contera Pharma Aps Pulsatile drug delivery system for treating morning akinesia
EP3590498A4 (en) * 2017-03-03 2020-12-16 CTC Bio, Inc. PREPARATION, INCLUDING AN INCLUSION COMPLEX OF VARENICLINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREFOR, FOR ORAL ADMINISTRATION
CN107028901A (zh) * 2017-03-29 2017-08-11 陈永雷 一种药品含片、功能性食品含片、保健食品含片区域分区制备法
CA3062146A1 (en) 2017-05-22 2018-11-29 Johnson & Johnson Consumer Inc. Lozenge dosage form
EP3906916A1 (en) 2017-12-08 2021-11-10 Fertin Pharma A/S Nicotine tablet
EP3720497A1 (en) 2017-12-08 2020-10-14 Fertin Pharma A/S High nicotine concentration
WO2019110073A1 (en) * 2017-12-08 2019-06-13 Fertin Pharma A/S Solid oral nicotine formulation
KR102810926B1 (ko) 2017-12-20 2025-05-22 퍼듀 퍼머 엘피 남용 억제 황산모르핀 제형
CN108250506A (zh) * 2018-02-12 2018-07-06 上海星宇医疗器材有限公司 一种亲水性牙根管充填尖及其制备方法
US11096896B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Tablet dosage form for buccal absorption of active ingredients
WO2020012009A1 (en) 2018-07-13 2020-01-16 Mcneil Ab Chewing gum comprising nicotine
US11759419B2 (en) * 2019-10-11 2023-09-19 Fertin Pharma A/S Compressed nicotine lozenge
US20230058142A1 (en) * 2019-12-10 2023-02-23 Adamed Pharma S.A. Liquid pharmaceutical composition comprising cytisine
CN114945359A (zh) 2020-01-15 2022-08-26 麦克内尔股份公司 口香糖的产品和制备方法
MX2022008737A (es) 2020-01-15 2022-07-21 Mcneil Ab Producto y metodo para fabricar una goma.
CN111053761B (zh) * 2020-01-16 2022-05-03 杭州旦承医药科技有限公司 一种吸入用双膦酸类药物及其制备方法及其在慢性阻塞性肺疾病的用途
US11179331B1 (en) 2020-04-21 2021-11-23 Cure Pharmaceutcai Holding Corp Oral soluble film containing sildenafil citrate
CN111419726A (zh) * 2020-04-30 2020-07-17 云南风联科技有限公司 一种植物陈皮烟草香型口腔雾化液及制备方法
PL244375B1 (pl) 2020-06-30 2024-01-22 Podkarpackie Centrum Innowacji Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja aerozolowa do jamy ustnej
CN112220757B (zh) * 2020-10-16 2022-05-27 重庆市义力医药科技有限公司 一种尼古丁颗粒组合物及其制备方法及其制备装置
CN112220756B (zh) * 2020-10-16 2023-06-13 重庆市义力医药科技有限公司 一种尼古丁颗粒组合物及其制备方法
CN113880802A (zh) * 2021-11-09 2022-01-04 深圳萨特瓦生物科技有限公司 酒石酸-尼古丁盐及其制备方法与应用、无水酒石酸晶体的制备方法
US11786473B2 (en) 2021-12-14 2023-10-17 Fertin Pharma A/S Nicotine tablet
CN118356022A (zh) * 2023-01-17 2024-07-19 思摩尔国际控股有限公司 一种尼古丁液体制剂及其制备方法和应用
WO2026057139A1 (en) * 2024-09-12 2026-03-19 Fertin Pharma A/S Fast dissolvable solid oral dosage form
CN120391718A (zh) * 2025-03-31 2025-08-01 爱奇迹创造有限公司 尼古丁口含制品及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
DK615689A (da) * 1989-11-07 1991-05-08 Anders Dam Rygesupplement eller rygeerstatningsprodukt
SE8904295D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Smoking substitute
FR2718020B1 (fr) * 1994-04-01 1996-05-31 Biotec Centre Sa Composition galénique mucoadhésive hétérofonctionnelle.
JP3706204B2 (ja) * 1996-08-09 2005-10-12 花王株式会社 口腔用固形製剤
JPH10236948A (ja) * 1996-08-09 1998-09-08 Kao Corp 口腔用固形製剤
DE19814257A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
AU776019B2 (en) * 1998-09-03 2004-08-26 Jsr Nti Llc Medicated chewing gum delivery system for nicotine
EP1231900A1 (en) * 1999-11-23 2002-08-21 The Robert Gordon University Bilayered buccal tablets comprising nicotine
US6607752B2 (en) * 2000-07-27 2003-08-19 Rohm And Haas Company Method for the anhydrous loading of nicotine onto ion exchange resins
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
JP5089840B2 (ja) 2001-09-25 2012-12-05 救急薬品工業株式会社 ニコチン含有フィルム製剤
US20040037879A1 (en) 2001-11-02 2004-02-26 Adusumilli Prasad S. Oral controlled release forms useful for reducing or preventing nicotine cravings
US7517681B2 (en) * 2003-01-29 2009-04-14 Biogaia Ab Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
CN104397869B (zh) * 2003-11-07 2016-06-08 美国无烟烟草有限责任公司 烟草组合物
JP2006232675A (ja) * 2005-02-22 2006-09-07 Kowa Co 複合型口腔内溶解用固形製剤
US20070269492A1 (en) 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
WO2008097539A2 (en) * 2007-02-05 2008-08-14 Jsrnti, Llc Multi-modal absorption, medicine-delivery lozenge, and use thereof
KR20090119960A (ko) * 2007-03-15 2009-11-23 토요 보세키 가부시기가이샤 구강 점막 첩부 부프레노르핀 제제의 제조 방법
US20090004248A1 (en) 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form

Also Published As

Publication number Publication date
EP2361081B1 (en) 2016-06-29
DK2361081T3 (en) 2016-08-15
JP2012505878A (ja) 2012-03-08
NZ591710A (en) 2012-11-30
CA2737307A1 (en) 2010-04-22
KR20110071008A (ko) 2011-06-27
AR073851A1 (es) 2010-12-09
ES2592882T3 (es) 2016-12-02
MX2011003984A (es) 2011-05-10
CN102186461A (zh) 2011-09-14
AU2009303979A1 (en) 2010-04-22
WO2010044736A1 (en) 2010-04-22
PT2361081T (pt) 2016-09-05
EP2361081A1 (en) 2011-08-31
EP2361081A4 (en) 2013-08-21
RU2011119494A (ru) 2012-11-27

Similar Documents

Publication Publication Date Title
BRPI0913822A2 (pt) forma farmacêutica oral e uso da forma farmacêutica
DK2300609T3 (da) Hidtil ukendt flagellinbaserede immunadjuvansforbindelser samt anvendelse deraf
BRPI0813955A2 (pt) composições terapêuticas e o uso das mesmas
BRPI0919438A2 (pt) mistura de poliésteres, e, uso das misturas de poliésteres
BRPI0815204A2 (pt) Dispositivo de administração fecal e utilização do dispositivo
EP2487146A4 (en) hONEYCOMB STRUCTURE
HRP20180718T1 (hr) Oligopeptidni spojevi i njihova upotreba
BRPI0819231A2 (pt) Forma de dosagem de desintegração oral
FI20075881A0 (fi) Lääketieteellinen väline ja sen käyttö
BR112012005736A2 (pt) di-hidro benzocicloalquiloximetil oxazolapirimidinonas substituídas, preparação e uso das mesmas
BRPI0818766A2 (pt) N-fenil-pirrolidinilmetilpirrolidinamidas substituídas e uso terapêutico das mesmas
DK2194959T3 (da) Skummedygtig mundplejetilberedning
ATE494839T1 (de) Gewebeentnahme
EP2197448A4 (en) dosing schedule
DE602008002077D1 (de) Hautpflegevorrichtung
BRPI0807882A2 (pt) Forma de dosagem
BRPI0810475A2 (pt) uso de dimiracetam no tratamento de dor crônica
BRPI0909096A2 (pt) uso de conjugados de interleicna-1 no tratamento de diabetes
EP2361092A4 (en) HEALTH CARE
UA14592S (uk) Стілець
ES1065657Y (es) Bañera fabricada en material de goma-caucho-silicona-gel
EE200900067A (et) Mutatsioonid inimese UBIAD1-s
UA18952S (uk) Крісло м`яке
UA18949S (uk) Крісло м`яке
UA18953S (uk) Крісло м`яке

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.